IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Ranbaxy Buys Biopharma Stake

1:20 PM MDT | October 22, 2007 | Chemical Week Editorial Staff

India’s largest pharmaceutical company Ranbaxy Laboratories (Gurgaon), says it has signed a definitive agreement to increase its stake in Zenotech Laboratories (Hyderabad, India) from 7%, to 45%. Zenotech develops and manufactures generic biopharmaceuticals and is a specialty generics injectable company. It also develops new biological entities in the areas of oncology and neurology. “The increasing importance of biologics in the global pharmaceutical industry and the opening up of generic biologics in the regulated markets makes it opportune for...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa